Skip to main content

Table 1 Thyroid function of the patient

From: Endocrine Manifestations in POEMS Syndrome: a case report and literature review

Date

FT3

(3.8–6.0 pmol/L)a

(3.5–6.5 pmol/L)b

FT4

(7.86–14.41 pmol/L)a

(11.5–23.5 pmol/L)b

TSH

(0.34–5.6 mIU/mL)a

(0.3–5.0 mIU/mL)b

TGAb

(0–40 IU/mL)

TPOAb

(0–35 IU/mL)

1st daya

2.88

9.73

10.520

< 20

< 10

23rd daya

3.67

9.25

9.889

–

–

8th montha

2.23

12.85

1.557

–

–

9th monthb

4.17

10.20

3.84

–

–

10th monthb

4.79

8.97

3.11

–

–

12th monthb,c

5.18

18.52

0.11

–

–

  1. aReference range of one hospital, breference range of another hospital, c after lenalidomide was administered, boldface type indicate values out of range